Searched for
HEALTHCARE COMPANY USV
Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
HUL shares in focus after FMCG major completes Rs 307 cr stake sale in Wellbeing NutritionHindustan Unilever has completed the sale of its stake in Wellbeing Nutrition for Rs 307 crore. USV Private Limited acquired a majority sta...
USV Pharma buys 79% stake in Wellbeing Nutrition for Rs 1,583 croreUSV Pharma has acquired a 79% stake in Wellbeing Nutrition for Rs 1,583 crore in an all-cash deal, expanding into India’s nutraceutical sup...
USV Pharma leads race to buy 85% stake in Wellbeing Nutrition at Rs 1,600 crore valuationThe Mumbai-based brand, owned by Nutritionlab, counts Hindustan Unilever and Fireside Ventures among its early backers. HUL and Fireside — ...
India’s most generous women gave over ₹600 cr in 2025; Rohini Nilekani tops the list with ₹204 crRohini Nilekani has been named India's most generous woman philanthropist, contributing ₹204 crore in the past year. Her focus on social in...
From OYO's Ritesh Agarwal to BlissClub's Minu Margaret: Check out 155 entrepreneurs in Hurun India's under-35 listAvendus Wealth and Hurun India have unveiled the U35 List, celebrating 155 exceptional young leaders under 35. These entrepreneurs are driv...
India’s probiotics market doubles in 5 years, hits Rs 2,070 cr in 2025India’s probiotics market recorded 22% annual growth in May, nearly doubling in five years from ₹1,016 crore in 2021 to ₹2,070 crore in 202...
Isha, Akash Ambani, Alakh Pandey in Hurun's under-35 list of entrepreneurs shaping India's economic futureReliance Retail's Isha Ambani and Parita Parekh from Toddle are the youngest women in the inaugural 2024 Hurun India Under35s list. The lis...
NCLT allows 936 days exclusion from Lok Housing’s resolution processAs per the bankruptcy regulation, the lenders and the resolution professional are expected to complete the resolution process within a tota...
Azim Premji remains top philanthropist with Rs 27 cr donation daily, Shiv Nadar & Mukesh Ambani followPremji increased his donation by nearly a fourth during the pandemic year.
Azim Premji donated Rs 27 cr per day in FY21, retains top giver rankPremji, the founder chairman of the company, increased his donation by nearly a fourth during the pandemic year, as per the Edelgive Hurun ...
EV infra startup Revos bags $4 million in fundingThe company will use the capital to deploy EV chargers across the country and strengthen its technology team, its founders told ET. It plan...
Baddi drug units feel side effects of virus curbsFifty pharmaceutical manufacturing facilities have shuttered their operations in Baddi, Himachal Pradesh, Asia’s largest pharmaceutical hub...
USV in talks with Novartis to buy Jalra Trademark for Rs. 200 CroreMumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal...
Smitha V Crishna, Roshni Nadar among richest Indian womenThe report by Kotak Wealth Hurun-Leading Wealthy Women 2018 featured 10 wealthiest Indian women.
Top stocks in focus on 14 December 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
How the NPPA has transformed itself into a watchdog with teeth under Bhupindra SinghThe man leading the charge is NPPA Chairman Bhupindra Singh, 57, who took charge at the beginning of last year.
Price cut: Drug makers' profitability may come under pressureLast week, NPPA announced that it plans to bring an additional 50 drugs belonging to the cardiovascular and anti-diabetic segment under pri...
Diabetes drug ban to help companies like USV, Sun Pharma, LupinIn the wake of a government ban on top-selling diabetes drug, pioglitazone , the volumes are expected to shift to other classes such as fir...
- Novartis ties up with USV to market Galvus in India
Novartis has tied up with leading healthcare company - USV - to market its anti-diabetic product Galvus.